Clinical trials in Gambia
89 studies list at least one site in Gambia. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2025-04-30.
Status
- Completed
- 67
- Status unknown
- 12
- Recruiting
- 5
- Active, not recruiting
- 2
- Terminated
- 2
- Not yet recruiting
- 1
Phase
- Phase 3
- 26
- Phase 2
- 14
- Phase 1
- 9
- Phase 4
- 6
- Early Phase 1
- 1
Most studied here
Who runs them
London School of Hygiene and Tropical Medicine (44) · University of Oxford (4) · Medical Research Council Unit, The Gambia (4) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · PATH (3) · GlaxoSmithKline (3) · The Aurum Institute NPC (2) · Medicines for Malaria Venture (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 89 — search for more.
- A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung DiseaseRecruitingNCT06909799Not applicable
- Seasonal R21 Mass Vaccination for Malaria EliminationRecruitingNCT06578572Phase 3
- The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM)RecruitingNCT05951751Not applicable
- A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy InfantsRecruitingNCT05447377Phase 3
- Childhood TB SequelRecruitingNCT05325125
- Permian Health Women's Lung Health StudyNot yet recruitingNCT06029543
- A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.CompletedNCT04424316Phase 3
- Enterics for Global Health (EFGH)Active, not recruitingNCT06047821
- Epidemiologic Study to Assess the IGRA Positivity in Populations With a High TB BurdenCompletedNCT05190146
- Cluster Randomized Trial of Peer Health Education in Malaria in The GambiaCompletedNCT00269178Phase 3
- Systems Biology to Identify Biomarkers of Neonatal Vaccine ImmunogenicityCompletedNCT03246230Not applicable
- Understanding COVID-19 Infections in Pregnant Women and Their Babies in 5 African Nations (periCOVID Africa)CompletedNCT05409274
- Early Childhood Malaria Prevention With Maloprim in The GambiaCompletedNCT00294580Phase 4
- Transmission of Respiratory Viruses in Households in The Gambia: a Longitudinal Cohort Study (TransVIR)Active, not recruitingNCT05952336
- Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation TrialCompletedNCT04394689Phase 1/2
- Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TBCompletedNCT03350048
- Streptococcus Pyogenes Carriage Acquisition and Transmission StudyCompletedNCT05117528
- Diagnostic and Prognostic Biomarkers for Childhood Bacterial PneumoniaCompletedNCT03996967
- Iron Babies Pilot Supplementation TrialCompletedNCT04751994Phase 3
- Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy InfantsCompletedNCT03896477Phase 3
- P. Falciparum Infection Dynamics and Transmission to Inform EliminationStatus unknownNCT04053907Not applicable
- HPV Vaccination in Africa- New Delivery Schedules Alias The HANDS HPV Vaccine TrialStatus unknownNCT03832049Phase 3
- Gambia Pertussis Study (GaPs)Status unknownNCT03606096Phase 4
- Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria EliminationCompletedNCT03576313Phase 3
- Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum MalariaCompletedNCT01594931Phase 2
- Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria PatientsCompletedNCT00422084Phase 3
- Health Behavior Change During COVID-19 PandemicCompletedNCT04367337
- Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)CompletedNCT03964012Phase 3
- Establishing Global Reference Values for Human MilkStatus unknownNCT03254329
- Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the GambiaStatus unknownNCT04703608Phase 3
- TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TBStatus unknownNCT03251196
- Maternal Immunization With MenAfriVac™Status unknownNCT03746665Phase 3
- Protecting From Pneumococcus in Early Life (The PROPEL Trial)Status unknownNCT02628886Phase 3
- PROLIFICA - West African Treatment Cohort for Hepatitis BCompletedNCT02129829
- RHOST-cRCT, Reactive Household-based Self-administered Treatment Against Residual Malaria TransmissionCompletedNCT02878200Not applicable
- Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy InfantsCompletedNCT03197376Phase 3
- Iron and Infection: Neonatal Nutritional ImmunityCompletedNCT03353051
- A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the GambiaCompletedNCT02972957Phase 4
- Pilot Evaluation of the Effect of Riboflavin Supplementation on Blood Pressure and Possible Effect Modification by the MTHFR C677T GenotypeTerminatedNCT03151096Not applicable
- An Observational Study Designed to Elucidate the Pathways by Which Inflammation Contributes to Anaemia in Sick Rural African Children From 6 Months to 36 MonthsStatus unknownNCT04095884
- Inflammation, Iron Deficiency and Anaemia Study 1Status unknownNCT04097639
- Pyramax in Asymptomatic Carriers of P. Falciparum MonoinfectionsStatus unknownNCT03814616Phase 2
- Genes-in-Action - Hepcidin Regulation of Iron SupplementationCompletedNCT03341338
- A Novel Nano-iron Supplement to Safely Combat Iron Deficiency and Anaemia in Young Children: a Doubleblind Randomised Controlled TrialCompletedNCT02941081Phase 2
- Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, InfantsCompletedNCT02308540Phase 1/2
- Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy InfantsCompletedNCT01098474Phase 2
- Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & InfantsCompletedNCT01262872Phase 2
- Malaria Prevalence in ChildrenCompletedNCT00322816
- Time to Infection With Malaria ParasitesCompletedNCT00322738
- Effectiveness of a Micronutrient Supplement to Lower Plasma Homocysteine MDEG2 Pilot Supplementation TrialCompletedNCT03431597Phase 2